Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03029091 · ClinicalTrials.gov registry record · Phase 2
An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)
A Phase 2 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT03029091 is a Phase 2 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 15 participants.
The verdict
NCT03029091, a Phase 2 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and effectiveness of Losartan potassium in subjects with eosinophilic esophagitis (EoE) including those with a connective tissue disorder (CTD) and those without a CTD.
Interventions
- DRUG Losartan Potassium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2019-08-22 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03029091
The ClinicalTrials.gov registry entry for NCT03029091 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Losartan Potassium is the first listed.
NCT03029091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03029091 about?
NCT03029091 is a clinical study titled "An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)". The purpose of this study is to test the safety and effectiveness of Losartan potassium in subjects with eosinophilic esophagitis (EoE) including those with a connective tissue disorder (CTD) and those without a CTD.
What is the current status of trial NCT03029091?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2017-05-23. Estimated completion is 2019-08-22.
What interventions are being tested in trial NCT03029091?
The interventions under investigation include: Losartan Potassium (DRUG).
Who is sponsoring clinical trial NCT03029091?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.